Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review.

Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. · 2012

Read Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. by Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3564748.txt.

Description

Lucy Turner and colleagues summarized a Cochrane review in Systematic Reviews in 2012 on the CONSORT Statement, a checklist meant to improve how randomized trials are reported. Poor reporting hides how a trial was run, so readers cannot judge its results. The question was whether journals that endorse the checklist publish trials described more completely than journals that do not.

The review gathered fifty evaluations covering 16,604 trials and scored reports against items from the CONSORT checklists. Across most comparisons, endorsement came with better reporting: sixty-nine of eighty-one analyses favored endorsing journals, and five outcomes improved by a margin the authors counted as clear. Gains were uneven, trials per analysis were often few, and many evaluations were judged weak. Even so, nothing suggested endorsement does harm, so the balance favors journals adopting the standard.

Catalog record

CREATORTurner L, Shamseer L, Altman DG, Schulz KF, Moher D.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3564748

Browse the full library · About the Tower of Babel